The Effect of Palliative Care Training on Symptom Management and Quality of Life in Chronic Heart Failure
NCT ID: NCT05285163
Last Updated: 2022-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2017-01-01
2018-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Focused Palliative Care Intervention in Advanced Heart Failure
NCT02805712
Palliative Care in Heart Failure
NCT01589601
Family Palliative and End-of-Life Care for Advanced Heart Failure
NCT04153890
Palliative Care for Heart Failure Patients
NCT01519479
Teach Back Method in Individuals With Heart Failure
NCT06060223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
palliative care education
The patients in the intervention group were presented palliative care training in addition to their usual care. The training period lasts at least 45 minutes. After the training, patients were given the book 'Palliative Care in Heart Failure'. In this training, patients were informed about heart failure and pharmacological and non-pharmacological methods for symptoms such as dyspnea, pain, constipation, depression, edema, tiredness, nausea. The patients were followed up by telephone at the first, third, and sixth months after discharge. The patient's symptoms and quality of life were re-evaluated in telephone follow-up. During the follow-up period, the patient's training related to symptoms was repeated. The patients were referred to the physician for the symptoms and problems which they experienced in the house.
palliative care educatiom
The patients in the intervention group were presented palliative care training in addition to their usual care
usual care
Firstly, the usual care provided to patients was described. It was determined that patients were not given regular and comprehensive training on heart failure, and no training was given on palliative care. Written educational material was not given to the patients. Patients were not followed up after discharge. Palliative care was not discussed with patients and their relatives. Also, they were not asked about their preferences. In usual care, Heart failure patients received medical treatment for their symptoms during hospitalization.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
palliative care educatiom
The patients in the intervention group were presented palliative care training in addition to their usual care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Class III and IV heart failure patients according to New York Heart Association (NYHA) classification,
* Patients without any communication problem to prevent participation in the research \[loss of hearing, visual impairment, lack of understanding/speaking in Turkish\], can be contacted by telephone, are literate.
* The patients who were diagnosed with heart failure at least six months ago accepted to participate voluntarily were also included in the study.
Exclusion Criteria
18 Years
86 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülşah Çamcı
Assistant Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülşah Çamcı, PhD
Role: PRINCIPAL_INVESTIGATOR
Marmara University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara U.
Istanbul, , Turkey (Türkiye)
Marmara University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MU-SBF-IHH-GC-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.